'Landmark moment' as vaccine stops deadly skin cancer returning in striking trial
A new personalised vaccine could halve the risk of skin cancer returning in high-risk patients, a large trial has found.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.dailymail.co.uk — the content belongs to Daily Mail Health.